Global Cardiac Marker Analyzer Market, By Region and Country, Product Analysis, Key Company’s Business & Marketing Strategy, Major Deals, Recent Developments – Forecast to 2028
The global cardiac marker analyzer market is projected to reach US$ 1,120 Million by 2028. Cardiac marker analyzer provides high-quality point-of-care testing solutions used to diagnose heart diseases such as myocardial infarction and other cardiac-related diseases. These devices measure the levels of enzymes and proteins released from the heart in cardiac conditions like myocardial infarction, atrial fibrillation, and others. Cardiac marker analyzers are important for the prevention of the misdiagnosis of cardiac conditions. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 20.5 million lives each year. The increasing number of hospital admissions and critical care unit admissions due to CVDs creates a demand for the availability of cardiac marker analyzers for better disease diagnosis. The factors such as the increasing incidences of cardiovascular diseases, a rapidly increasing geriatric population, growing funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the market. However, factors such as the issues related to regulatory and reimbursement processes and the high cost of the instruments are likely to hamper the growth of this market.
Recent Developments
In April 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc., a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
In September 2022, SRL Diagnostics, one of the chains of diagnostic laboratories in India, launched 'Heart Assure,' a specialized high-sensitivity Troponin I (hsTnI) test that can predict the risk of a cardiac event in the target population.
Siemens Healthineers launched the third phase of its Strategy 2025 with the beginning of fiscal year 2022.
By Geography: Global Cardiac Marker Analyzer Market & Forecast – Key Takeaways
North America dominated the global cardiac marker analyzer market.
The United States dominates the cardiac marker analyzer market, due to increasing demand for point-of-care testing devices, rising focus on providing immediate diagnostic and treatment services to cardiac patients, and new product launches by major players.
Europe contributed second highest share to the global cardiac marker analyzer market in 2022, driven by the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and growing awareness about the benefits of early diagnosis.
Germany dominated the European cardiac marker analyzer market by country.
In the UK, there are around 7.6 million people living with a heart or circulatory disease.
Asia Pacific cardiac marker analyzer market is expected to grow at the fastest pace over the forecast period owing to rising affordability for advanced cardiac tests, modernization in the countries, and increasing disposable income. The rising prevalence and incidence of cardiovascular diseases in the region, especially in China and India, is expected to drive the demand for cardiac marker analyzers over the forecast period.
iGATE RESEARCH report titled “Global Cardiac Marker Analyzer Market, By Region and Country, Product Analysis, Key Company’s Business & Marketing Strategy, Major Deals, Recent Developments – Forecast to 2028” provides a comprehensive assessment of the cardiac marker analyzer market.
This 146 Page report with 18 Figures and 31 Tables has been studied from 10 View Points:
1. Global - Cardiac Marker Analyzer Market & Forecast (2015 - 2028)
2. Global - Cardiac Marker Analyzer Market Share & Forecast (2015 - 2028)
3. By Region - Cardiac Marker Analyzer Market & Forecast (2015 - 2028)
4. By Country - Cardiac Marker Analyzer Market & Forecast (2015 - 2028)
5. Cardiac Marker Companies - Comparative Tests Analysis and Business & Marketing Strategy
6. Cardiac Marker Analyzer - Competitive Product Analysis
7. Cardiac Marker Analyzer - Specifications, Product Features & Benefits Analysis
8. Cardiac Marker Analyzer - Mergers, Acquisitions, Distribution, Partnership and Licensing Agreements
9. Emerging Markers Analysis
10. Recent Developments
By Geography - Cardiac Marker Analyzer Market & Forecast
1. North America
United States
Canada
2. Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
3. Asia Pacific
Japan
China
India
Australia
South Korea
Rest of APAC
4. Latin America
Brazil
Mexico
Rest of Latin America
5. Middle East & Africa
Saudi Arabia
UAE
Egypt
Rest of Middle East & Africa
The Cardiac Marker Analyzers Covered in the report are as follows:
1. Triage MeterPro Analyzer
2. The i-STAT System
3. Cobas h 232 POC System
4. Access 2 Immunoassay System
5. Stratus CS Analyzer
6. RAMP 200
7. RAMP Reader
8. i-chroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. QL Care Analyzer
12. Meritas POC Analyzer
Cardiac Marker Analyzer - Key Company Analysis
1. Alere (Now Abbott)
2. Abbott Point of Care
3. Quidel Corporation
4. Roche
5. Beckman Coulter
6. Siemens Healthineers
7. Response Biomedical
8. Boditech Med Inc.
9. Lifesign
10. LSI Medience Corporation
11. CardioGenics Holdings Inc.
12. Trinity Biotech
Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Recent Developments
In April 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc., a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
In September 2022, SRL Diagnostics, one of the chains of diagnostic laboratories in India, launched 'Heart Assure,' a specialized high-sensitivity Troponin I (hsTnI) test that can predict the risk of a cardiac event in the target population.
Siemens Healthineers launched the third phase of its Strategy 2025 with the beginning of fiscal year 2022.
By Geography: Global Cardiac Marker Analyzer Market & Forecast – Key Takeaways
North America dominated the global cardiac marker analyzer market.
The United States dominates the cardiac marker analyzer market, due to increasing demand for point-of-care testing devices, rising focus on providing immediate diagnostic and treatment services to cardiac patients, and new product launches by major players.
Europe contributed second highest share to the global cardiac marker analyzer market in 2022, driven by the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and growing awareness about the benefits of early diagnosis.
Germany dominated the European cardiac marker analyzer market by country.
In the UK, there are around 7.6 million people living with a heart or circulatory disease.
Asia Pacific cardiac marker analyzer market is expected to grow at the fastest pace over the forecast period owing to rising affordability for advanced cardiac tests, modernization in the countries, and increasing disposable income. The rising prevalence and incidence of cardiovascular diseases in the region, especially in China and India, is expected to drive the demand for cardiac marker analyzers over the forecast period.
iGATE RESEARCH report titled “Global Cardiac Marker Analyzer Market, By Region and Country, Product Analysis, Key Company’s Business & Marketing Strategy, Major Deals, Recent Developments – Forecast to 2028” provides a comprehensive assessment of the cardiac marker analyzer market.
This 146 Page report with 18 Figures and 31 Tables has been studied from 10 View Points:
1. Global - Cardiac Marker Analyzer Market & Forecast (2015 - 2028)
2. Global - Cardiac Marker Analyzer Market Share & Forecast (2015 - 2028)
3. By Region - Cardiac Marker Analyzer Market & Forecast (2015 - 2028)
4. By Country - Cardiac Marker Analyzer Market & Forecast (2015 - 2028)
5. Cardiac Marker Companies - Comparative Tests Analysis and Business & Marketing Strategy
6. Cardiac Marker Analyzer - Competitive Product Analysis
7. Cardiac Marker Analyzer - Specifications, Product Features & Benefits Analysis
8. Cardiac Marker Analyzer - Mergers, Acquisitions, Distribution, Partnership and Licensing Agreements
9. Emerging Markers Analysis
10. Recent Developments
By Geography - Cardiac Marker Analyzer Market & Forecast
1. North America
United States
Canada
2. Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
3. Asia Pacific
Japan
China
India
Australia
South Korea
Rest of APAC
4. Latin America
Brazil
Mexico
Rest of Latin America
5. Middle East & Africa
Saudi Arabia
UAE
Egypt
Rest of Middle East & Africa
The Cardiac Marker Analyzers Covered in the report are as follows:
1. Triage MeterPro Analyzer
2. The i-STAT System
3. Cobas h 232 POC System
4. Access 2 Immunoassay System
5. Stratus CS Analyzer
6. RAMP 200
7. RAMP Reader
8. i-chroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. QL Care Analyzer
12. Meritas POC Analyzer
Cardiac Marker Analyzer - Key Company Analysis
1. Alere (Now Abbott)
2. Abbott Point of Care
3. Quidel Corporation
4. Roche
5. Beckman Coulter
6. Siemens Healthineers
7. Response Biomedical
8. Boditech Med Inc.
9. Lifesign
10. LSI Medience Corporation
11. CardioGenics Holdings Inc.
12. Trinity Biotech
Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
1. EXECUTIVE SUMMARY
2. GLOBAL CARDIAC MARKER ANALYZER MARKET & FORECAST (2015 - 2028)
3. GLOBAL CARDIAC MARKER ANALYZER MARKET SHARE & FORECAST - BY GEOGRAPHY (2015 - 2028)
4. GEOGRAPHICAL DISTRIBUTION - GLOBAL CARDIAC MARKER ANALYZER MARKET & FORECAST (2015 - 2028)
4.1 North America - Cardiac Marker Analyzer Market & Forecast
4.1.1 By Country - North America Cardiac Marker Analyzer Market & Forecast
4.2 Europe - Cardiac Marker Analyzer Market & Forecast
4.2.1 By Country - Europe Cardiac Marker Analyzer Market & Forecast
4.3 Asia Pacific - Cardiac Marker Analyzer Market & Forecast
4.3.1 By Country – Asia Pacific Cardiac Marker Analyzer Market & Forecast
4.4 Latin America - Cardiac Marker Analyzer Market & Forecast
4.4.1 By Country - Latin America Cardiac Marker Analyzer Market & Forecast
4.5 Middle East & Africa - Cardiac Marker Analyzer Market & Forecast
4.5.1 By Country - Middle East & Africa Cardiac Marker Analyzer Market & Forecast
5. CARDIAC MARKER COMPANIES - COMPARATIVE TESTS ANALYSIS
6. CARDIAC MARKER ANALYZER - COMPETITIVE PRODUCT ANALYSIS
7. ALERE (NOW ABBOTT)
7.1 Alere Triage
7.1.1 Alere Cardiology Net Sales (2010 - 2016)
8. QUIDEL CORPORATION
8.1 Quidel Triage system
8.1.1 Quidel Cardiac Immunoassay Net Sales (2017 – 2022e)
9. ABBOTT POINT OF CARE
9.1 The i-STAT System
9.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 - 2028)
10. ROCHE
10.1 Cobas h 232 POC System
11. BECKMAN COULTER
11.1 Access 2 Immunoassay System
12. SIEMENS HEALTHINEERS
12.1 Stratus CS Analyzer
13. RESPONSE BIOMEDICAL
13.1 Cardiovascular Testing
13.1.1 Acute Myocardial Infarction (Heart Attack) Testing
13.1.2 Congestive Heart Failure (“CHF”) Testing
13.1.3 Thrombotic Disease Testing
13.2 RAMP Platform
13.2.1 RAMP
13.2.2 RAMP Reader
13.3 Response Cardiovascular Testing
13.3.1 RAMP TROPONIN I
13.3.2 RAMP NT-proBNP
13.3.3 RAMP MYOGLOBIN
13.3.4 RAMP CK-MB
13.3.5 RAMP D-DIMER
13.4 Response Biomedical Cardiovascular Net Sales (2010 - 2028)
14. BODITECH
14.1 i-chroma II Analyzer
15. LIFESIGN
15.1 DXpress Reader Analyzer
16. LSI MEDIENCE CORPORATION
16.1 PATHFAST Analyzer
17. CARDIOGENICS HOLDINGS INC.
17.1 QL Care Analyzer
18. TRINITY BIOTECH
18.1 Meritas POC Analyzer
19. MERGERS, ACQUISITIONS AND LICENSING AGREEMENTS
19.1 Alere Inc.
19.2 CardioGenics
19.3 Response Biomedical
19.4 Abbott Laboratories
19.5 Siemens Healthineers
19.6 LSI Medience Corporation
19.7 Trinity Biotech
19.8 Quidel
20. EMERGING MARKERS
21. RESPONSE BIOMEDICAL - BUSINESS & MARKETING STRATEGY
22. ROCHE - BUSINESS & MARKETING STRATEGY
23. BODITECH MED INC. - BUSINESS AND MARKETING STRATEGY
24. SIEMENS HEALTHINEERS - BUSINESS AND MARKETING STRATEGY
25. RECENT DEVELOPMENTS
2. GLOBAL CARDIAC MARKER ANALYZER MARKET & FORECAST (2015 - 2028)
3. GLOBAL CARDIAC MARKER ANALYZER MARKET SHARE & FORECAST - BY GEOGRAPHY (2015 - 2028)
4. GEOGRAPHICAL DISTRIBUTION - GLOBAL CARDIAC MARKER ANALYZER MARKET & FORECAST (2015 - 2028)
4.1 North America - Cardiac Marker Analyzer Market & Forecast
4.1.1 By Country - North America Cardiac Marker Analyzer Market & Forecast
4.2 Europe - Cardiac Marker Analyzer Market & Forecast
4.2.1 By Country - Europe Cardiac Marker Analyzer Market & Forecast
4.3 Asia Pacific - Cardiac Marker Analyzer Market & Forecast
4.3.1 By Country – Asia Pacific Cardiac Marker Analyzer Market & Forecast
4.4 Latin America - Cardiac Marker Analyzer Market & Forecast
4.4.1 By Country - Latin America Cardiac Marker Analyzer Market & Forecast
4.5 Middle East & Africa - Cardiac Marker Analyzer Market & Forecast
4.5.1 By Country - Middle East & Africa Cardiac Marker Analyzer Market & Forecast
5. CARDIAC MARKER COMPANIES - COMPARATIVE TESTS ANALYSIS
6. CARDIAC MARKER ANALYZER - COMPETITIVE PRODUCT ANALYSIS
7. ALERE (NOW ABBOTT)
7.1 Alere Triage
7.1.1 Alere Cardiology Net Sales (2010 - 2016)
8. QUIDEL CORPORATION
8.1 Quidel Triage system
8.1.1 Quidel Cardiac Immunoassay Net Sales (2017 – 2022e)
9. ABBOTT POINT OF CARE
9.1 The i-STAT System
9.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 - 2028)
10. ROCHE
10.1 Cobas h 232 POC System
11. BECKMAN COULTER
11.1 Access 2 Immunoassay System
12. SIEMENS HEALTHINEERS
12.1 Stratus CS Analyzer
13. RESPONSE BIOMEDICAL
13.1 Cardiovascular Testing
13.1.1 Acute Myocardial Infarction (Heart Attack) Testing
13.1.2 Congestive Heart Failure (“CHF”) Testing
13.1.3 Thrombotic Disease Testing
13.2 RAMP Platform
13.2.1 RAMP
13.2.2 RAMP Reader
13.3 Response Cardiovascular Testing
13.3.1 RAMP TROPONIN I
13.3.2 RAMP NT-proBNP
13.3.3 RAMP MYOGLOBIN
13.3.4 RAMP CK-MB
13.3.5 RAMP D-DIMER
13.4 Response Biomedical Cardiovascular Net Sales (2010 - 2028)
14. BODITECH
14.1 i-chroma II Analyzer
15. LIFESIGN
15.1 DXpress Reader Analyzer
16. LSI MEDIENCE CORPORATION
16.1 PATHFAST Analyzer
17. CARDIOGENICS HOLDINGS INC.
17.1 QL Care Analyzer
18. TRINITY BIOTECH
18.1 Meritas POC Analyzer
19. MERGERS, ACQUISITIONS AND LICENSING AGREEMENTS
19.1 Alere Inc.
19.2 CardioGenics
19.3 Response Biomedical
19.4 Abbott Laboratories
19.5 Siemens Healthineers
19.6 LSI Medience Corporation
19.7 Trinity Biotech
19.8 Quidel
20. EMERGING MARKERS
21. RESPONSE BIOMEDICAL - BUSINESS & MARKETING STRATEGY
22. ROCHE - BUSINESS & MARKETING STRATEGY
23. BODITECH MED INC. - BUSINESS AND MARKETING STRATEGY
24. SIEMENS HEALTHINEERS - BUSINESS AND MARKETING STRATEGY
25. RECENT DEVELOPMENTS
LIST OF FIGURES:
Figure 2-1: Global - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 2-2: Global - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-1: North America - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-2: North America - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-3: Europe - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-4: Europe - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-5: Asia Pacific - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-6: Asia Pacific - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-7: Latin America - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-8: Latin America - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-9: Middle East & Africa - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-10: Middle East & Africa - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 7-1: Global - Alere Cardiology Net Sales (Million US$), 2010 - 2016
Figure 8-1: Quidel - Cardiac Immunoassay Revenue (Million US$), 2017 – 2022e
Figure 9-1: Global - Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 - 2022
Figure 9-2: Global - Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2023 - 2028
Figure 13-1: Global - Response Biomedical Cardiovascular Product Sales (Million US$), 2010 - 2022
Figure 13-2: Global - Forecast for Response Biomedical Cardiovascular Product Sales (Million US$), 2023 - 2028
Figure 2-1: Global - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 2-2: Global - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-1: North America - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-2: North America - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-3: Europe - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-4: Europe - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-5: Asia Pacific - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-6: Asia Pacific - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-7: Latin America - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-8: Latin America - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 4-9: Middle East & Africa - Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Figure 4-10: Middle East & Africa - Forecast for Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Figure 7-1: Global - Alere Cardiology Net Sales (Million US$), 2010 - 2016
Figure 8-1: Quidel - Cardiac Immunoassay Revenue (Million US$), 2017 – 2022e
Figure 9-1: Global - Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 - 2022
Figure 9-2: Global - Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2023 - 2028
Figure 13-1: Global - Response Biomedical Cardiovascular Product Sales (Million US$), 2010 - 2022
Figure 13-2: Global - Forecast for Response Biomedical Cardiovascular Product Sales (Million US$), 2023 - 2028
LIST OF TABLES:
Table 3-1: By Geography - Cardiac Marker Analyzer Market Share (Percent), 2015 - 2022
Table 3-2: By Geography - Forecast for Cardiac Marker Analyzer Market Share (Percent), 2023 - 2028
Table 4-1: By Country - North America Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-2: By Country - Forecast for North America Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 4-3: By Country - Europe Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-4: By Country - Forecast for Europe Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 4-5: By Country - Asia Pacific Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-6: By Country - Forecast for Asia Pacific Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 4-7: By Country - Latin America Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-8: By Country - Forecast for Latin America Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 4-9: By Country - Middle East & Africa Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-10: By Country - Forecast for Middle East & Africa Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 5-1: Cardiac Marker Companies - Comparative Tests Analysis
Table 5-2: Cardiac Marker Companies - Comparative Tests Analysis
Table 5-3: Cardiac Marker Companies - Comparative Tests Analysis
Table 6-1: Cardiac Marker Analyzer - Competitive Product Analysis
Table 6-2: Cardiac Marker Analyzer - Competitive Product Analysis
Table 7-1: Alere - Triage Product Analytes
Table 16-1: PATHFAST - Technical Specifications
Table 19-1: Alere - Merger & Acquisition, 2007 - 2017
Table 19-2: Alere - Distribution/Partnership Agreement, 2008, 2016
Table 19-3: CardioGenics - Mergers & Acquisition, 2015
Table 19-4: CardioGenics - Licensing Agreement, 2012
Table 19-5: Response Biomedical - Distribution Agreement, 2011 - 2015
Table 19-6: Response Biomedical - Collaboration Deal, 2004 - 2015
Table 19-7: Abbott Laboratories - Merger & Acquisition, 2003, 2017, 2023
Table 19-8: Siemens Healthineers - Merger & Acquisition, 2017
Table 19-9: Siemens Healthineers - Strategic Partnership, 2017
Table 19-10: LSI Medience Corporation - Strategic Alliance, 2014
Table 19-11: Trinity Biotech - Merger & Acquisition, 2012
Table 19-12: Quidel Corporation - Merger & Acquisition, 2017
Table 3-1: By Geography - Cardiac Marker Analyzer Market Share (Percent), 2015 - 2022
Table 3-2: By Geography - Forecast for Cardiac Marker Analyzer Market Share (Percent), 2023 - 2028
Table 4-1: By Country - North America Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-2: By Country - Forecast for North America Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 4-3: By Country - Europe Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-4: By Country - Forecast for Europe Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 4-5: By Country - Asia Pacific Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-6: By Country - Forecast for Asia Pacific Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 4-7: By Country - Latin America Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-8: By Country - Forecast for Latin America Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 4-9: By Country - Middle East & Africa Cardiac Marker Analyzer Market (Million US$), 2015 - 2022
Table 4-10: By Country - Forecast for Middle East & Africa Cardiac Marker Analyzer Market (Million US$), 2023 - 2028
Table 5-1: Cardiac Marker Companies - Comparative Tests Analysis
Table 5-2: Cardiac Marker Companies - Comparative Tests Analysis
Table 5-3: Cardiac Marker Companies - Comparative Tests Analysis
Table 6-1: Cardiac Marker Analyzer - Competitive Product Analysis
Table 6-2: Cardiac Marker Analyzer - Competitive Product Analysis
Table 7-1: Alere - Triage Product Analytes
Table 16-1: PATHFAST - Technical Specifications
Table 19-1: Alere - Merger & Acquisition, 2007 - 2017
Table 19-2: Alere - Distribution/Partnership Agreement, 2008, 2016
Table 19-3: CardioGenics - Mergers & Acquisition, 2015
Table 19-4: CardioGenics - Licensing Agreement, 2012
Table 19-5: Response Biomedical - Distribution Agreement, 2011 - 2015
Table 19-6: Response Biomedical - Collaboration Deal, 2004 - 2015
Table 19-7: Abbott Laboratories - Merger & Acquisition, 2003, 2017, 2023
Table 19-8: Siemens Healthineers - Merger & Acquisition, 2017
Table 19-9: Siemens Healthineers - Strategic Partnership, 2017
Table 19-10: LSI Medience Corporation - Strategic Alliance, 2014
Table 19-11: Trinity Biotech - Merger & Acquisition, 2012
Table 19-12: Quidel Corporation - Merger & Acquisition, 2017
